AXA IM Prime Impact Master Fund I SCA SICAV-RAIF - Former 10% Owner at Revelation Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Former 10% Owner
Stock Symbol
REVB, REVBW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by AXA IM Prime Impact Master Fund I SCA SICAV-RAIF since 11/5/2023

Holdings reported by AXA IM Prime Impact Master Fund I SCA SICAV-RAIF for Revelation Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 1.96M $1.02M $0.52 Jan 10, 2022 Direct

Transactions reported by AXA IM Prime Impact Master Fund I SCA SICAV-RAIF for Revelation Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.